Trademark: 90759395
Word
RHENIUM SCT
Status
Pending
Status Code
733
Status Date
Tuesday, December 26, 2023
Serial Number
90759395
Mark Type
4000
Filing Date
Monday, June 7, 2021
Published for Opposition
Tuesday, November 9, 2021

Trademark Owner History
OncoBeta International GmbH - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cancer, namely, radio therapeutic preparations and radio diagnostic preparations used in the application of radioisotopes and radiation for medical purposes in the nature of nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy, diagnostics and therapy of pain, diagnostics and therapy of inflammations, diagnostics and therapy of metabolic disorders, palliative therapy, ablative therapy, positrons emission tomography, emission tomography with single photons, x-ray diagnostics, gamma spectrometry, nuclear spin tomography, scintigraphy, and dosimetry
44 Medical services, particularly services in the field of radiologic and nuclear-medical medicine, radiation oncology and for the treatment of skin cancer, none of the foregoing services involving stem cell therapy
10 Medical instruments and apparatus for dosimetry purposes in the field of radiotherapy, namely, apparatus for radiation therapy with radio therapeutic substance compounds; containers specially designed for holding radiopharmaceuticals sold as an integral component of apparatus for radiation therapy with radio therapeutic substance compounds; radiation dosimeters for assessing therapeutic doses of radiation delivered to patients; medical devices and instruments for introducing pharmaceutical preparations and diagnostic preparations into the human body, namely, radioactive isotope generators being medical radiation apparatus and microfluidics instruments being radioisotope therapy apparatus for therapy with radio therapeutic substance compounds; medical apparatus and instruments for diagnostic radiopharmaceutical use for the application of pharmaceutical preparations and diagnostic preparations, namely, apparatus for radiation therapy with radio therapeutic substance compounds; radioisotope therapy apparatus and instruments for the application of pharmaceutical preparations and diagnostic preparations, namely, apparatus for radiation therapy with radio therapeutic substance compounds; control, regulation and measuring apparatuses, namely, scintillation counters sold as an integral component of medical radiation apparatus, medical dose meter that measures the total radiation dose received by a patient during a diagnostic procedure, and radiation dosimeters for assessing therapeutic doses of radiation delivered to patients, all the foregoing comprising parts of medical instruments and devices for radiation therapy with a radio therapeutic substance
"RHENIUM"

Trademark Events
Dec 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 26, 2023
Sou Extension 4 Granted
Dec 26, 2023
Sou Extension 4 Filed
Dec 26, 2023
Sou Teas Extension Received
Jul 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2023
Sou Extension 3 Granted
Jun 29, 2023
Sou Extension 3 Filed
Jun 29, 2023
Sou Teas Extension Received
Jan 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 2, 2023
Sou Extension 2 Granted
Jan 2, 2023
Sou Extension 2 Filed
Jan 2, 2023
Sou Teas Extension Received
Jun 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2022
Sou Extension 1 Granted
Jun 28, 2022
Sou Extension 1 Filed
Jun 28, 2022
Sou Teas Extension Received
May 17, 2022
Assigned To Examiner
Jan 4, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 9, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Published For Opposition
Oct 20, 2021
Notification Of Notice Of Publication E-Mailed
Oct 1, 2021
Approved For Pub - Principal Register
Sep 17, 2021
Examiner's Amendment Entered
Sep 17, 2021
Notification Of Examiners Amendment E-Mailed
Sep 17, 2021
Examiners Amendment E-Mailed
Sep 17, 2021
Examiners Amendment -Written
Sep 9, 2021
Assigned To Examiner
Aug 27, 2021
New Application Office Supplied Data Entered
Jun 10, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24